CrystalGenomics Inc (083790) — Cash Flow-to-Debt Ratio
CrystalGenomics Inc (083790) has a Cash Flow-to-Debt Ratio of -0.09x as of September 2025, meaning its operating cash flow of ₩-11.39 Billion could theoretically repay 0% of its total liabilities (₩124.24 Billion) in one year. Explore CrystalGenomics Inc long-term investment allocation to see how much of total assets are deployed in long-term investments.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
CrystalGenomics Inc Cash Flow-to-Debt Ratio (2014–2024)
Historical debt coverage capacity for CrystalGenomics Inc across 11 annual periods. Also explore 083790 total assets for the complete picture of this company's asset base.
Annual Cash Flow-to-Debt Ratio for CrystalGenomics Inc (2014–2024)
Year-by-year debt coverage analysis for CrystalGenomics Inc. For market capitalisation and broader financial context, see CrystalGenomics Inc stock valuation.
| Year | CF-to-Debt Ratio | Operating CF (KRW) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2024 | -0.16x | ₩-25.85 Billion | ₩161.95 Billion | ▲ +51.8% |
| 2023 | -0.33x | ₩-32.41 Billion | ₩97.82 Billion | ▼ -82.4% |
| 2022 | -0.18x | ₩-24.40 Billion | ₩134.34 Billion | ▼ -98.3% |
| 2021 | -0.09x | ₩-11.46 Billion | ₩125.09 Billion | ▲ +42.9% |
| 2020 | -0.16x | ₩-16.38 Billion | ₩102.20 Billion | ▼ -416.9% |
| 2019 | -0.03x | ₩-7.14 Billion | ₩230.14 Billion | ▼ -86.2% |
| 2018 | -0.02x | ₩-1.21 Billion | ₩72.45 Billion | ▼ -128.4% |
| 2017 | 0.06x | ₩1.63 Billion | ₩27.88 Billion | ▲ +132.1% |
| 2016 | -0.18x | ₩-8.30 Billion | ₩45.51 Billion | ▼ -113.6% |
| 2015 | -0.09x | ₩-4.73 Billion | ₩55.34 Billion | ▼ -16.1% |
| 2014 | -0.07x | ₩-3.75 Billion | ₩51.02 Billion | — |